Navigation Links
Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
Date:4/30/2008

- Mikael Dohlsten, M.D., Ph.D., To Succeed As President, Wyeth Research -

MADISON, N.J., April 30 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced that Robert R. Ruffolo, Jr., Ph.D., 58, will retire as President, Wyeth Research and Senior Vice President, Wyeth, later this year. He will be succeeded by Mikael Dohlsten, M.D., Ph.D.

Dr. Ruffolo joined Wyeth in November 2000 and has been responsible for all pharmaceutical research and development (R&D) for the Company, including discovery, drug safety and metabolism, chemical and pharmaceutical development, clinical R&D and research operations.

"Bob Ruffolo has been the driving force of our R&D progress, establishing Wyeth as one of the research leaders in the pharmaceutical industry," says Bernard Poussot, Wyeth's President and Chief Executive Officer. "His legacy will be our pipeline, recognized as one of the industry's most innovative. Bob has helped position our company for future growth through robust research and development programs in oncology, women's health, vaccines, inflammation, cardiovascular and metabolic diseases and neuroscience -- led by our multi-platform effort in Alzheimer's."

Throughout his 31-year career in the pharmaceutical industry, Dr. Ruffolo's work has been recognized with a number of prestigious awards. In March, he was recognized by the Pharmaceutical Research and Manufacturers of America (PhRMA) with the 2008 Discoverer's Award for his efforts in the discovery and development of Coreg(R) while at GlaxoSmithKline. The Wyeth Research and Development Executive Team (RADEX), formed and chaired by Dr. Ruffolo, won the 2006 Scrip Award for Management Team of the Year. In 2005, he won the George B. Koelle Award for Scientific Excelle
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Wyeth Chairman Robert Essner Announces June 27 Retirement
2. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
3. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
4. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
5. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
6. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
7. Wyeth Announces Executive Change in Finance Organization
8. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
9. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
11. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...if., July 2 Advanced Chemical Tra...s in California, has announced a multi-year partne...hird largest Bio-Med company. , , ACT will prov...aterials disposal, vacuum truck services, spill re...nagement support from its corporate headquarters i...
(Date:7/2/2009)... N.Y., July 2 Lixte Biot...unced today that investigators of the National Ins...) and the National Cancer Institute (NCI), Nationa... novel compound, LB-1.2, enhances the effectivenes...ls of human cancers. This research is being conduc...
(Date:7/1/2009)...cal analysis technique that identifies and removes...cts from experimental data could lead to more prec...nanostructures likely to have future industrial ap...ment by regression (SPAR), the technique could als...to make conclusions, and help distinguish true nan...
(Date:7/1/2009)... July 1 Cellular Dynamics Intern...gnificant expansion of their existing agreement to...ial to cause cardiotoxicity, or damage to heart ti...rug safety testing in order to bring promising the...ement, CDI will supply purified cardiomyocytes, cr...
Breaking Biology Technology:Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 2Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 3New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 3
...n advice offered , ,Waukesha, Wis. Whenever a ne..., it seldom begins its life as an instant success....r impractical contraption that is waiting for earl...o become successful, it must be studied by those e...itions and purchased enough so early adopters beco...
...has formed a scientific advisory board to guide th...s. , ,Announced last week by President and Chief ...onsist of distinguished scientific leaders who wil...edge within Quintessence Biosciences, Inc. They wi... and evaluates its drug development plan, includin...
...nt Bush proclaimed that health care in America is ...alth care system [which] uses a 19th century paper...ent, Dr. William Yasnoff , a physician and compute... National Health Information Infrastructure at th...too generous. , ,According to Yasnoff, the health ...
...hered in Wisconsin yesterday to debate how inform...nt safety and quality healthcare. The discussion ...Healthcare Conference and was presented by UW He...hool, College of Engineering and School of Nursing... Wisconsin Technology Network. Attendees and spea...
Other Biology Technology:Laying the foundation for RFID 2Laying the foundation for RFID 3Laying the foundation for RFID 4Quintessence Biosciences forms cancer therapeutic advisory board 2Federal advisor to HHS describes the national information infrastructure 2Federal advisor to HHS describes the national information infrastructure 3Federal advisor to HHS describes the national information infrastructure 4Building a improved national health care infrastructure 2Building a improved national health care infrastructure 3Building a improved national health care infrastructure 4
(Date:7/2/2009)... proteins that are highly effective at killing bac...ew types of antibiotics. , Researchers from the ....3m from the Biotechnology and Biological Sciences... of proteins known as colicins force their way int...team, led by Professor Colin Kleanthous, from the ...
(Date:7/2/2009)...t DNA-based reconstruction of the giant extinct mo...caves and rock shelters in New Zealand. , Resear... Research in New Zealand have identified four diff...m moa feathers believed to be at least 2500 years ...es and weighing 250 kilograms were the dominant a...
(Date:7/1/2009)... been associated with the formation of metastases ...Delbrck Center for Molecular Medicine (MDC) Berlin...any, have identified 115 genes that are disregulat.... In the future, their findings may help identify ...e ( Gastroenterology 2009, doi:10.1053/j.gastro.2...
(Date:7/1/2009)...of Science Education-Biology at the University of ...rigating" mechanism of the desert rhubarb, which e...than otherwise expected for a plant in this region...is is the first example of a self-irrigating plant...untains of Israel,s Negev desert, where average pr...
Breaking Biology News(10 mins):Scientists 'rebuild' giant moa using ancient DNA 2Colorectal cancer 2Desert rhubarb -- a self-irrigating plant 2With Prostate Cancer 3A Waiting for Symptoms Is Not an Option 23017 1With Prostate Cancer 3A Waiting for Symptoms Is Not an Option 23017 2Chem Rx Corporation Surpasses 67 000 Beds Served 23013 1Chem Rx Corporation Surpasses 67 000 Beds Served 23013 2Industry Veterans Join Molecular Imprints Management Team 6328 1Industry Veterans Join Molecular Imprints Management Team 6328 2Industry Veterans Join Molecular Imprints Management Team 6328 3Bad News to Bad Bugs 3A Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity 2567 1Bad News to Bad Bugs 3A Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity 2567 2
...d a novel behavior in krill that may help regulate...gest animal resources on Earth, parachute into the... sequester large amounts carbon in the process. ,...itish Antarctic Survey and Magnus Johnson of the S...f Hull. , Krill are shrimp-like crustaceans that ...
... prevent the onset of another is not new. For exam...t smallpox dates back to 1798. , Dr. E. Richard St...dren,s Hospital at UCLA, researched examples throu...vents another. , His findings suggest that geneti...onsidered when looking for treatments, particularl...
...ted a genetically engineered mosquito that shows a...nt type of dengue fever virus, providing a powerfu... people each year. , Anthony James, a UC Irvine ve...o injected DNA into mosquito embryos, creating the...e 2 dengue fever virus, the most prevalent strain ...
...brain cells play an important role in regulating b...he basic assumptions underlying today,s most sophi... new frontier when it comes to understanding Alzhe...uary issue of Nature Neuroscience and now availabl...er Medical Center demonstrate that star-shaped bra...
Other Biology News:UCLA paper examines how one disease may prevent another 2Genetically engineered mosquitoes show resistance to dengue fever virus 2Genetically engineered mosquitoes show resistance to dengue fever virus 3Blood flow in brain takes a twist, affecting views of Alzheimer's 2Blood flow in brain takes a twist, affecting views of Alzheimer's 3
Flexi Rabbit Reticulocyte Lysate System from Promega
10% Normal Goat Serum from Invitrogen
Pyrophosphate Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
m7G(5)ppp(5)G (Cap Analog) from Ambion
Biology Products: